MediciNova
MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. MediciNova’s pipeline includes clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers
Domain
medicinova.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$30.0M
Founded
1999
Tech Stack (13 technologies)
Frequently Asked Questions
What technologies does MediciNova use?+
MediciNova uses 13 technologies including MetaSlider, WordPress, jQuery.
What industry is MediciNova in?+
MediciNova operates in the Biotechnology industry.
Where is MediciNova based?+
MediciNova is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026